BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1633729)

  • 1. Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells.
    Aiello A; Delia D; Borrello MG; Biassoni D; Giardini R; Fontanella E; Pezzella F; Pulford K; Pierotti M; Della Porta G
    Cytometry; 1992; 13(5):502-9. PubMed ID: 1633729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle analysis of p26-BCL-2 protein levels in proliferating lymphoma and leukemia cell lines.
    Reed JC; Tanaka S; Cuddy M
    Cancer Res; 1992 May; 52(10):2802-5. PubMed ID: 1581893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
    Gratiot-Deans J; Ding L; Turka LA; Nuñez G
    J Immunol; 1993 Jul; 151(1):83-91. PubMed ID: 8326141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
    Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
    Gaidano G; Pastore C; Volpe G
    Haematologica; 1995; 80(5):454-72. PubMed ID: 8566891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
    Hockenbery D; Nuñez G; Milliman C; Schreiber RD; Korsmeyer SJ
    Nature; 1990 Nov; 348(6299):334-6. PubMed ID: 2250705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
    Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
    Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
    Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on bcl-2 protein in cultured lymphoid cells.
    Filip A; Rozynkowa D
    Cell Biol Int; 1994 Feb; 18(2):95-102. PubMed ID: 8019487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].
    Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A
    Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
    Ngan BY; Chen-Levy Z; Weiss LM; Warnke RA; Cleary ML
    N Engl J Med; 1988 Jun; 318(25):1638-44. PubMed ID: 3287162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the apoptosis-suppressing oncoprotein bcl-2 in salivary gland lymphoma.
    Takahashi H; Fujita S; Shibata Y; Okabe H; Hideshima K; Tsuda N
    Pathol Res Pract; 1998; 194(3):163-70. PubMed ID: 9587934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.
    Liu YJ; Mason DY; Johnson GD; Abbot S; Gregory CD; Hardie DL; Gordon J; MacLennan IC
    Eur J Immunol; 1991 Aug; 21(8):1905-10. PubMed ID: 1868875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease.
    Pescarmona E; Lo Coco F; Pacchiarotti A; Rapanotti MC; Cimino G; Di Paolo B; Baroni CD
    J Pathol; 1995 Sep; 177(1):21-5. PubMed ID: 7472775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the Bcl-2 protein to the outer mitochondrial membrane by electron microscopy.
    Riparbelli MG; Callaini G; Tripodi SA; Cintorino M; Tosi P; Dallai R
    Exp Cell Res; 1995 Dec; 221(2):363-9. PubMed ID: 7493635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 protein in centrocytic lymphoma; a paraffin section study.
    Swerdlow SH; Utz GL; Williams ME
    Leukemia; 1993 Sep; 7(9):1456-8. PubMed ID: 8371594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas.
    Brown DM; Phipps RP
    J Immunol; 1996 Aug; 157(4):1359-70. PubMed ID: 8759715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.
    Alkan S; Ross CW; Hanson CA; Schnitzer B
    Mod Pathol; 1995 Jun; 8(5):544-7. PubMed ID: 7675775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.
    Kondo E; Yoshino T; Yamadori I; Matsuo Y; Kawasaki N; Minowada J; Akagi T
    Am J Pathol; 1994 Aug; 145(2):330-7. PubMed ID: 7519826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.